Idiopathic pneumatosis intestinalis secondary to lactulose use in patients with cirrhosis

J Gastroenterol Hepatol. 2020 Jun;35(6):1065-1068. doi: 10.1111/jgh.14920. Epub 2019 Dec 9.

Abstract

Background and aim: Few case reports exist that link lactulose use with pneumatosis intestinalis in cirrhotics. This study investigates the relationship between lactulose use and idiopathic pneumatosis intestinalis in a cohort of cirrhotic patients.

Methods: This case series considers several notable cases of patients with idiopathic pneumatosis intestinalis and concurrent lactulose use. Idiopathic pneumatosis intestinalis was defined as pneumatosis intestinalis with no identifiable etiology. A cohort of 119 patients with cirrhosis and pneumatosis intestinalis were identified in a tertiary care setting, via chart review by a multidisciplinary team. Eleven of these patients were found to have idiopathic pneumatosis intestinalis. Nine of these patients were being treated with lactulose.

Results: Six out of 9 patients with idiopathic pneumatosis intestinalis that were being treated with lactulose saw resolution of pneumatosis intestinalis following discontinuation of treatment.

Conclusions: The etiology of idiopathic pneumatosis intestinalis is likely multifactorial, but lactulose might play a preventable role in its formation.

Keywords: hepatic encephalopathy; lactulose; liver cirrhosis; liver imaging; pneumatosis intestinalis.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Cohort Studies
  • Female
  • Gastrointestinal Agents / adverse effects*
  • Humans
  • Lactulose / adverse effects*
  • Liver Cirrhosis / drug therapy*
  • Male
  • Middle Aged
  • Pneumatosis Cystoides Intestinalis / etiology*

Substances

  • Gastrointestinal Agents
  • Lactulose